Argentine hemorrhagic fever. Alterations of the complement system and anti-Junin-virus humoral response. 1978

M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana

We investigated immunologic mechanisms and the role of complement in the pathogenesis of Argentine hemorrhagic fever, a disease caused by the Junin virus, a member of the arenavirus group. Total serum complement activity was reduced to 68 per cent of control values in patients with severe or moderate disease (P less than 0.001). C2, C3 and C5 values were also low (12 to 60 per cent) during the early acute period of the disease. However, serum C4 content was increased to 160 per cent of the control values in the same patients. Total complement activity returned to normal with clinical and laboratory recovery, at the time of detection of antibodies against Junin virus. C1q reactive material was found in four of 19 cases and no relation to the evolution of the disease could be established. These results suggest that immune complexes are not important in the pathogenesis of Argentine hemorrhagic fever, but that activation of the complement system has a role.

UI MeSH Term Description Entries
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003175 Complement C2 A component of the CLASSICAL COMPLEMENT PATHWAY. C2 is cleaved by activated COMPLEMENT C1S into COMPLEMENT C2B and COMPLEMENT C2A. C2a, the COOH-terminal fragment containing a SERINE PROTEASE, combines with COMPLEMENT C4B to form C4b2a (CLASSICAL PATHWAY C3 CONVERTASE) and subsequent C4b2a3b (CLASSICAL PATHWAY C5 CONVERTASE). C2 Complement,Complement 2,Complement Component 2,C2, Complement,Complement, C2,Component 2, Complement
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D003182 Complement C5 C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX. C5 Complement,Complement 5,Complement C5, Precursor,Complement Component 5,Precursor C5,Pro-C5,Pro-complement 5,C5, Complement,C5, Precursor,C5, Precursor Complement,Complement, C5,Component 5, Complement,Precursor Complement C5,Pro C5,Pro complement 5
D003289 Convalescence The period of recovery following an illness. Convalescences
D006477 Arenaviruses, New World One of two groups of viruses in the ARENAVIRUS genus and considered part of the New World complex. It includes JUNIN VIRUS; PICHINDE VIRUS; Amapari virus, and Machupo virus among others. They are the cause of human hemorrhagic fevers mostly in Central and South America. Amapari virus,Chapare mammarenavirus,Hemorrhagic Fever Virus, Bolivian,Hemorrhagic Fever Viruses, American,Machupo virus,New World Arenaviruses,Sabia virus,Tacaribe virus,Allpahuayo virus,American Hemorrhagic Fever Virus,Chapare virus,Guanarito virus,Pirital virus,Tacaribe Complex Viruses,Allpahuayo viruses,Chapare mammarenaviruses,Chapare viruses,Guanarito viruses,Pirital viruses,Tacaribe viruses,viruses, Tacaribe
D006478 Hemorrhagic Fever, American Diseases caused by American hemorrhagic fever viruses (ARENAVIRUSES, NEW WORLD). American Hemorrhagic Fever,Argentine Hemorrhagic Fever,Bolivian Hemorrhagic Fever,Brazilian Hemorrhagic Fever,Hemorrhagic Fever, Argentinian,Hemorrhagic Fever, Bolivian,Hemorrhagic Fever, Brazilian,Junin virus Infection,Machupo virus Infection,Sabia virus Infection,American Hemorrhagic Fevers,Argentinian Hemorrhagic Fever,Bolivian Hemorrhagic Fevers,Brazilian Hemorrhagic Fevers,Fever, American Hemorrhagic,Fever, Argentine Hemorrhagic,Fever, Argentinian Hemorrhagic,Fever, Bolivian Hemorrhagic,Fever, Brazilian Hemorrhagic,Hemorrhagic Fever, Argentine,Infection, Junin virus,Infection, Machupo virus,Infection, Sabia virus,Junin virus Infections,Machupo virus Infections,Sabia virus Infections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
January 1979, Intervirology,
M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
May 1969, Comptes rendus des seances de la Societe de biologie et de ses filiales,
M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
January 1966, Archiv fur die gesamte Virusforschung,
M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
May 2014, Journal of virology,
M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
January 1989, Reviews of infectious diseases,
M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
January 1986, Intervirology,
M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
March 1986, Antimicrobial agents and chemotherapy,
M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
December 1992, The American journal of tropical medicine and hygiene,
M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
January 1983, Journal of medical virology,
M M de Bracco, and M T Rimoldi, and P M Cossio, and A Rabinovich, and J I Maiztegui, and G Carballal, and R M Arana
January 1988, Intervirology,
Copied contents to your clipboard!